MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CATX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Perspective Therapeutics (CATX) Ownership - Who owns Perspective Therapeutics?

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
140
Web
https://www.perspectivetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
336.44M
P/E Ratio
N/A
Total Cash
270.93M
Projected Growth
N/A
Total Debt
4.23M
Revenue
N/A
Risk (Beta)
0.99
Dividend Yield
N/A
Total Cash/Share
2.38
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CATX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CATX
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalNursingServices

Profile
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
140
Web
https://www.perspectivetherapeutics.com